He Yao, Director of the Macau Center for Translational Medicine, noted that since its establishment in March 2024, the center has focused on precision diagnosis and treatment of eye and brain diseases and anti-aging research. It has partnered with leading institutions like Springer Nature Group and the Institute of Translational Medicine at Shanghai Jiao Tong University and has also hosted the “Belt and Road” International Forum on Great Health. He emphasized that the new center will further promote the clinical application of biomedical findings, help traditional Chinese medicine overcome development bottlenecks, and foster the appropriate diversification of Macau’s economy.
Song Haitao, President of the Shanghai AI Research Institute, said that Shanghai is home to one-third of China’s core AI enterprises and possesses clinical data from top hospitals and a mature biomedical industry chain, which will provide solid technical support for the collaboration. In the future, the center plans to build an international demonstration platform that integrates traditional Chinese and Western medicine. It also aims to leverage Macau’s advantage in connecting with Portuguese-speaking countries to promote the smart and international development of traditional Chinese medicine.
